Literature DB >> 3944225

Factors influencing mortality in rheumatoid arthritis.

D P Symmons, P Prior, D L Scott, R Brown, C F Hawkins.   

Abstract

The prognosis in rheumatoid arthritis respecting mortality was studied in a consecutive series of 489 hospital patients over a period of 18 years. The relative risk of mortality was raised in both men (2.6; p less than 0.001) and women (3.4; p less than 0.001). In the women the relative risk was also influenced by prior duration of RA and was characterised by a diminution in risk 5-9 years after first presentation. Relative risks for men were more uniformly distributed over time. Annual excess mortality rates were strongly associated with age at first presentation in women, the rate increasing with increasing age in both the group seen within 5 years of onset of disease (chi 2(1) for trend = 30.4; p less than 0.001) and in the later referral group (chi 2(1) = 34.0; p less than 0.001). A similar but much less marked effect was observed in men in the early referral group (chi 2(1) = 13.7; p less than 0.001) only. These results suggest that initially women may have a milder form of disease and that hormonal status may affect prognosis. Future long-term therapeutic studies in RA should take into account the prognostic factors of age, sex and duration of disease.

Entities:  

Mesh:

Year:  1986        PMID: 3944225     DOI: 10.1016/0021-9681(86)90070-6

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  9 in total

Review 1.  Lymphoma in patients with rheumatoid arthritis: what is the evidence of a link with methotrexate?

Authors:  L Georgescu; S A Paget
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

Review 2.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

Review 3.  A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Authors:  A A Kalla; A F Tooke; E Bhettay; O L Meyers
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

4.  Australian mortality statistics for rheumatoid arthritis 1950-81: analysis of death certificate data.

Authors:  I P Wicks; J Moore; A Fleming
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

5.  Early remission is associated with improved survival in patients with inflammatory polyarthritis: results from the Norfolk Arthritis Register.

Authors:  Carlo A Scirè; Mark Lunt; Tarnya Marshall; Deborah P M Symmons; Suzanne M M Verstappen
Journal:  Ann Rheum Dis       Date:  2013-06-07       Impact factor: 19.103

6.  UK-South Asian patients' experiences of and satisfaction toward receiving information about biologics in rheumatoid arthritis.

Authors:  Kanta Kumar; Sabrina R Raizada; Christian D Mallen; Rebecca J Stack
Journal:  Patient Prefer Adherence       Date:  2018-04-04       Impact factor: 2.711

7.  Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence.

Authors:  Daniela Iacono; Elvira Favoino; Alessia Borgia; Serena Fasano; Ilenia Pantano; Virginia D'Abrosca; Giuseppe Picillo; Rosa Daniela Grembiale; Federico Perosa; Gabriele Valentini
Journal:  Open Access Rheumatol       Date:  2018-09-06

8.  The impact of using musculoskeletal ultrasound imaging and other influencing factors on medication adherence in patients with rheumatoid arthritis: a qualitative study.

Authors:  Kanta Kumar; Karim Raza; Paramjit Gill; Sheila Greenfield
Journal:  Patient Prefer Adherence       Date:  2016-06-16       Impact factor: 2.711

9.  Mortality in Italian patients with rheumatoid arthritis: evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center.

Authors:  Daniela Iacono; Serena Fasano; Virginia D'Abrosca; Ilenia Pantano; Gabriele Valentini
Journal:  Open Access Rheumatol       Date:  2017-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.